Cell culture protection andin vivo neuroprotective capacity of flavonoids
- 1 January 2003
- journal article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 5 (6) , 425-432
- https://doi.org/10.1007/bf03033172
Abstract
Flavonoids are an important group of recognized antioxidants ubiquitous in fruits, vegetables and herbs. There are epidemiological evidences for the stroke-protecting capacity of flavonoids and while the neuroprotective power of complex extracts rich in flavonoids like those of Ginkgo biloba, green tea or lyophilized red wine have been demonstrated in several studies, neuroprotection by individual flavonoids has been poorly studiedin vivo. The neuroprotective capacity of individual flavonoids was studied in PC12 cells in culture and in a model of permanent focal ischemia (permanent Middle Cerebral Artery Occlusion — pMCAO). In thein vivo experiments, flavonoids were administered in lecithin preparations to facilitate the crossing of the blood brain barrier. The simultaneous incubation of PC12 cells with 200 μM hydrogen peroxide (H2O2) and different flavonoids for 30 min resulted in a conspicuous profile: quercetin, fisetin, luteolin and myricetin significantly increased cell survival while catechin, kaempherol and taxifolin did not. Quercetin was detected in brain tissue 30 min and 1 h after intraperitoneal administration. When one of the protective flavonoids (quercetin) and one of those that failed to increase PC12 cell survival (catechin) were assessed for their protective capacity in the pMCAO model, administered i.p. 30 min after vessel occlusion, quercetin significantly decreased the brain ischemic lesion while catechin did not. It is concluded that when administered in liposomal preparations, flavonoids structurally related to quercetin could become leads for the development of a new generation of molecules to be clinically effective in human brain ischemia.Keywords
This publication has 32 references indexed in Scilit:
- Interference of Plant Extracts, Phytoestrogens and Antioxidants with the MTT Tetrazolium AssayPlanta Medica, 2002
- Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley ratsJournal of Neuroscience Research, 2002
- Anti-apoptotic effect of quercetin: Intervention in the JNK- and ERK-mediated apoptotic pathwaysKidney International, 2000
- The Role of Vitamin E in the Prevention of Heart DiseaseArchives of Family Medicine, 1999
- Structure–activity relationships of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells11Mention of a trade name, proprietary product or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.Free Radical Biology & Medicine, 1999
- Myricetin and quercetin, the flavonoid constituents ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+-loaded brain neuronsBrain Research, 1994
- Suppression of active oxygen-induced cytotoricity by flavonoidsBiochemical Pharmacology, 1993
- An improved MIT assayJournal of Immunological Methods, 1993
- Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assayJournal of Neuroscience Methods, 1987
- Rapid colorimetric assay for cell growth and survivalJournal of Immunological Methods, 1986